Cargando…
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
BACKGROUND: In patients with Parkinson’s disease (PD), real-time quaking-induced conversion (RT-QuIC) detection of pathological α-synuclein (α-syn) in olfactory mucosa (OM) is not as accurate as in other α-synucleinopathies. It is unknown whether these variable results might be related to a differen...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330656/ https://www.ncbi.nlm.nih.gov/pubmed/35902902 http://dx.doi.org/10.1186/s40035-022-00311-3 |
_version_ | 1784758215489093632 |
---|---|
author | Bongianni, Matilde Catalan, Mauro Perra, Daniela Fontana, Elena Janes, Francesco Bertolotti, Claudio Sacchetto, Luca Capaldi, Stefano Tagliapietra, Matteo Polverino, Paola Tommasini, Valentina Bellavita, Giulia Kachoie, Elham Ataie Baruca, Roberto Bernardini, Andrea Valente, Mariarosaria Fiorini, Michele Bronzato, Erika Tamburin, Stefano Bertolasi, Laura Brozzetti, Lorenzo Cecchini, Maria Paola Gigli, Gianluigi Monaco, Salvatore Manganotti, Paolo Zanusso, Gianluigi |
author_facet | Bongianni, Matilde Catalan, Mauro Perra, Daniela Fontana, Elena Janes, Francesco Bertolotti, Claudio Sacchetto, Luca Capaldi, Stefano Tagliapietra, Matteo Polverino, Paola Tommasini, Valentina Bellavita, Giulia Kachoie, Elham Ataie Baruca, Roberto Bernardini, Andrea Valente, Mariarosaria Fiorini, Michele Bronzato, Erika Tamburin, Stefano Bertolasi, Laura Brozzetti, Lorenzo Cecchini, Maria Paola Gigli, Gianluigi Monaco, Salvatore Manganotti, Paolo Zanusso, Gianluigi |
author_sort | Bongianni, Matilde |
collection | PubMed |
description | BACKGROUND: In patients with Parkinson’s disease (PD), real-time quaking-induced conversion (RT-QuIC) detection of pathological α-synuclein (α-syn) in olfactory mucosa (OM) is not as accurate as in other α-synucleinopathies. It is unknown whether these variable results might be related to a different distribution of pathological α-syn in OM. Thus, we investigated whether nasal swab (NS) performed in areas with a different coverage by olfactory neuroepithelium, such as agger nasi (AN) and middle turbinate (MT), might affect the detection of pathological α-syn. METHODS: NS was performed in 66 patients with PD and 29 non-PD between September 2018 and April 2021. In 43 patients, cerebrospinal fluid (CSF) was also obtained and all samples were analyzed by RT-QuIC for α-syn. RESULTS: In the first round, 72 OM samples were collected by NS, from AN (NS(AN)) or from MT (NS(MT)), and 35 resulted positive for α-syn RT-QuIC, including 27/32 (84%) from AN, 5/11 (45%) from MT, and 3/29 (10%) belonging to the non-PD patients. Furthermore, 23 additional PD patients underwent NS at both AN and MT, and RT-QuIC revealed α-syn positive in 18/23 (78%) NS(AN) samples and in 10/23 (44%) NS(MT) samples. Immunocytochemistry of NS preparations showed a higher representation of olfactory neural cells in NS(AN) compared to NS(MT). We also observed α-syn and phospho-α-syn deposits in NS from PD patients but not in controls. Finally, RT-QuIC was positive in 22/24 CSF samples from PD patients (92%) and in 1/19 non-PD. CONCLUSION: In PD patients, RT-QuIC sensitivity is significantly increased (from 45% to 84%) when NS is performed at AN, indicating that α-syn aggregates are preferentially detected in olfactory areas with higher concentration of olfactory neurons. Although RT-QuIC analysis of CSF showed a higher diagnostic accuracy compared to NS, due to the non-invasiveness, NS might be considered as an ancillary procedure for PD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40035-022-00311-3. |
format | Online Article Text |
id | pubmed-9330656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93306562022-07-28 Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease Bongianni, Matilde Catalan, Mauro Perra, Daniela Fontana, Elena Janes, Francesco Bertolotti, Claudio Sacchetto, Luca Capaldi, Stefano Tagliapietra, Matteo Polverino, Paola Tommasini, Valentina Bellavita, Giulia Kachoie, Elham Ataie Baruca, Roberto Bernardini, Andrea Valente, Mariarosaria Fiorini, Michele Bronzato, Erika Tamburin, Stefano Bertolasi, Laura Brozzetti, Lorenzo Cecchini, Maria Paola Gigli, Gianluigi Monaco, Salvatore Manganotti, Paolo Zanusso, Gianluigi Transl Neurodegener Research BACKGROUND: In patients with Parkinson’s disease (PD), real-time quaking-induced conversion (RT-QuIC) detection of pathological α-synuclein (α-syn) in olfactory mucosa (OM) is not as accurate as in other α-synucleinopathies. It is unknown whether these variable results might be related to a different distribution of pathological α-syn in OM. Thus, we investigated whether nasal swab (NS) performed in areas with a different coverage by olfactory neuroepithelium, such as agger nasi (AN) and middle turbinate (MT), might affect the detection of pathological α-syn. METHODS: NS was performed in 66 patients with PD and 29 non-PD between September 2018 and April 2021. In 43 patients, cerebrospinal fluid (CSF) was also obtained and all samples were analyzed by RT-QuIC for α-syn. RESULTS: In the first round, 72 OM samples were collected by NS, from AN (NS(AN)) or from MT (NS(MT)), and 35 resulted positive for α-syn RT-QuIC, including 27/32 (84%) from AN, 5/11 (45%) from MT, and 3/29 (10%) belonging to the non-PD patients. Furthermore, 23 additional PD patients underwent NS at both AN and MT, and RT-QuIC revealed α-syn positive in 18/23 (78%) NS(AN) samples and in 10/23 (44%) NS(MT) samples. Immunocytochemistry of NS preparations showed a higher representation of olfactory neural cells in NS(AN) compared to NS(MT). We also observed α-syn and phospho-α-syn deposits in NS from PD patients but not in controls. Finally, RT-QuIC was positive in 22/24 CSF samples from PD patients (92%) and in 1/19 non-PD. CONCLUSION: In PD patients, RT-QuIC sensitivity is significantly increased (from 45% to 84%) when NS is performed at AN, indicating that α-syn aggregates are preferentially detected in olfactory areas with higher concentration of olfactory neurons. Although RT-QuIC analysis of CSF showed a higher diagnostic accuracy compared to NS, due to the non-invasiveness, NS might be considered as an ancillary procedure for PD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40035-022-00311-3. BioMed Central 2022-07-28 /pmc/articles/PMC9330656/ /pubmed/35902902 http://dx.doi.org/10.1186/s40035-022-00311-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Bongianni, Matilde Catalan, Mauro Perra, Daniela Fontana, Elena Janes, Francesco Bertolotti, Claudio Sacchetto, Luca Capaldi, Stefano Tagliapietra, Matteo Polverino, Paola Tommasini, Valentina Bellavita, Giulia Kachoie, Elham Ataie Baruca, Roberto Bernardini, Andrea Valente, Mariarosaria Fiorini, Michele Bronzato, Erika Tamburin, Stefano Bertolasi, Laura Brozzetti, Lorenzo Cecchini, Maria Paola Gigli, Gianluigi Monaco, Salvatore Manganotti, Paolo Zanusso, Gianluigi Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease |
title | Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease |
title_full | Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease |
title_fullStr | Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease |
title_full_unstemmed | Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease |
title_short | Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease |
title_sort | olfactory swab sampling optimization for α-synuclein aggregate detection in patients with parkinson’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330656/ https://www.ncbi.nlm.nih.gov/pubmed/35902902 http://dx.doi.org/10.1186/s40035-022-00311-3 |
work_keys_str_mv | AT bongiannimatilde olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT catalanmauro olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT perradaniela olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT fontanaelena olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT janesfrancesco olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT bertolotticlaudio olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT sacchettoluca olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT capaldistefano olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT tagliapietramatteo olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT polverinopaola olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT tommasinivalentina olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT bellavitagiulia olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT kachoieelhamataie olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT barucaroberto olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT bernardiniandrea olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT valentemariarosaria olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT fiorinimichele olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT bronzatoerika olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT tamburinstefano olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT bertolasilaura olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT brozzettilorenzo olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT cecchinimariapaola olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT gigligianluigi olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT monacosalvatore olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT manganottipaolo olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease AT zanussogianluigi olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease |